Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT07264647. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PK, PD, Tolerability and Safety of MDPK67b in Healthy Volunteers
ClinicalTrials.gov study NCT04839120. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma
ClinicalTrials.gov study NCT05394337. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation and Importance of the PD-1/PD-L1 and the IL-10/IL-10R Axis in Malignant and Benign Pleural Effusions - a Pilot Study
ClinicalTrials.gov study NCT04834830. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT05780307. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT05342792. IPD Sharing: YES. Countries: 1. Publications: 0.
A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy
ClinicalTrials.gov study NCT04151563. IPD Sharing: Not stated. Countries: 10. Publications: 0.
Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors
ClinicalTrials.gov study NCT05225584. IPD Sharing: NO. Countries: 1. Publications: 0.
PK, PD and Safety of Tegoprazan 12.5 mg After Oral Administration in Healthy Subjects
ClinicalTrials.gov study NCT06332638. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study for PD-1 Antibody JS001 in MSI-H Advanced or Recurrent Colorectal Cancer
ClinicalTrials.gov study NCT04118933. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenvatinib Plus PD-1 Antibody Versus Lenvtinib Alone for Advanced HCC
ClinicalTrials.gov study NCT03744247. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MIRT and Rotigotine in the Early Stage of PD
ClinicalTrials.gov study NCT02100176. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Cl
ClinicalTrials.gov study NCT06794073. IPD Sharing: NO. Countries: 0. Publications: 0.
Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer
ClinicalTrials.gov study NCT05426005. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neuroprotective Effects of iTBS in PD
ClinicalTrials.gov study NCT05445505. IPD Sharing: NO. Countries: 1. Publications: 0.
PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer
ClinicalTrials.gov study NCT05310305. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)
ClinicalTrials.gov study NCT07303699. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects With Advanced Cervical Cancer (FERMATA)
ClinicalTrials.gov study NCT03912415. IPD Sharing: NO. Countries: 4. Publications: 0.
Electrophysiology-based DBS Programming for PD
ClinicalTrials.gov study NCT07348705. IPD Sharing: Not stated. Countries: 1. Publications: 0.
L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH
ClinicalTrials.gov study NCT05775705. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.